← Back to headlines
TD Cowen Cautious on Amicus Therapeutics (FOLD) Despite Positive 2025 Revenue Projections
TD Cowen maintains a cautious outlook on Amicus Therapeutics (FOLD) even with positive revenue projections for 2025.
19 Feb, 00:38 — 19 Feb, 00:38
Sources
Showing 1 of 1 sources


